Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Osimertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Osimertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Abemaciclib	CDK Inhibitor	Solid Tumour
Molecule Abemaciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Ribociclib	CDK Inhibitor	Solid Tumour
Molecule Ribociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Palbociclib	CDK Inhibitor	Solid Tumour
Molecule Palbociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Olaparib	PARP Inhibitor	Solid Tumour
Molecule Olaparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Dabrafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Dabrafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Lenvatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Lenvatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lorlatinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Lorlatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Capivasertib	AKT Inhibitor	Solid Tumour
Molecule Capivasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Encorafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Encorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Adagrasib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Adagrasib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Adavosertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Adavosertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)

Osimertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Abemaciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Ribociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Palbociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Olaparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Dabrafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Lenvatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lorlatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Capivasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Encorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Adagrasib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Adavosertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)

‹ 1 2 3 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Osimertinib

Abemaciclib

Ribociclib

Palbociclib

Olaparib

Dabrafenib

Lenvatinib

Lorlatinib

Capivasertib

Encorafenib

Adagrasib

Adavosertib

Osimertinib

Abemaciclib

Ribociclib

Palbociclib

Olaparib

Dabrafenib

Lenvatinib

Lorlatinib

Capivasertib

Encorafenib

Adagrasib

Adavosertib